Silicon Valley Advantage

Our Services

ACCELERATOR

We help startups expand in the US. Our advisors take on active operating and advisory roles within the company, providing their expertise and guidance. Our involvement is long term, often lasting until exit.

INNOVATION LAB

Our innovation lab supports in-house inventors develop revolutionary ideas. We help with the patent process and finding strategic connections.

IP LICENSING

We build startups around revolutionary IP brought to us by inventors, licensed from universities, and generated in our innovation lab. After formation, we stay with our startups until exit.

Our Exit Ethos

We plan each startup's exit from the very beginning of our relationship. With that goal in mind, we commit to a long term partnership to ensure the highest chance of success possible. In our experience, continued support leads to the best results.

Our Approach

WE MAKE SILICON VALLEY ACCESSIBLE

We allow global startups to leverage the funding, knowledge, and networks available in Silicon Valley, without having to move.

WE STAY WITH OUR COMPANIES FOR 3-5 YEARS

Most accelerators stay with their startups for 3 months. We invest more time because we are personally tied to the success of our startups.

WE ADD ADVISORS TO THE TEAM

The US market is complex. We pair our experienced advisors with each startup to help steer them toward success and avoid failure.

Areas of Expertise

Life Sciences
Medical Devices
Drug Discovery
Development
Biotechnology
Agriculture Technology

Artificial Intelligence
Edge Computing
Internet of Things
Machine Learning
Semi-Conductor
Software
Sensors

Business Formation
Business Structure
Marketing
Business Plan Creation

Global leader of PIN-authenticated hard drives, flash drives, and encryption modules.

Disposable, IoT, pH sensors.

Epidural syringe that provides real-time objective and quantitative pressure information.

AI-enabled autonomous structural health sensing for concrete and other materials.

Edge powered security systems.

Big data acceleration.

Breakthrough innovative drug for multiple myeloma.

Intracellular delivery of macro molecules.

Find Out What's New

News & Events

Our Partners

SVA has an agreement with the Taiwanese accelerator, Taiwan Tech Arena (TTA), to review their selected startups from three research centers and multiple universities. TTA is a Taiwan accelerator that is funded by the Ministry of Science and Technology. Each year, 40-45 companies come to the US for SVA to review. TTA also invites SVA to Taiwan to meet over 100 startups twice a year.

The results have been excellent. Six startups have been accepted into the program so far, eight are under consideration, one is ready for exit, and three are ready for funding.